Nuvalent Newsroom

A Quick Look at Today's Ratings for Nuvalent(NUVL.US), With a Forecast Between $100 to $135

Futu NewsSep 17 21:00

Nuvalent Price Target Raised to $132.00/Share From $102.00 by BMO Capital

Dow JonesSep 16 21:04

A Quick Look at Today's Ratings for Nuvalent(NUVL.US), With a Forecast Between $100 to $135

Futu NewsSep 16 21:00

Nuvalent Is Maintained at Buy by Stifel

Dow JonesSep 16 20:12

Nuvalent Analyst Ratings

BenzingaSep 16 20:02

Wedbush Raises Price Target on Nuvalent to $115 From $99, Keeps Outperform Rating

MT NewswiresSep 16 19:08

Nuvalent (NUVL) Gets a Buy From Barclays

TipRanksSep 16 15:27

Goldman Sachs Remains a Sell on Nuvalent (NUVL)

TipRanksSep 16 13:09

Buy Rating Affirmed: Nuvalent's Rapid Clinical Progress and Best-in-Class Drug Profile Signal Strong Future Success

TipRanksSep 15 22:48

Baird Maintains Nuvalent(NUVL.US) With Buy Rating, Maintains Target Price $105

Futu NewsSep 11 00:32

Jefferies Maintains Nuvalent(NUVL.US) With Buy Rating, Maintains Target Price $97

Futu NewsSep 10 20:33

Piper Sandler Maintains Nuvalent(NUVL.US) With Buy Rating, Maintains Target Price $100

Futu NewsSep 10 04:31

Nuvalent Price Target Maintained With a $99.00/Share by Wedbush

Dow JonesSep 9 20:47

Nuvalent Analyst Ratings

BenzingaSep 9 20:39

Buy Rating Affirmed for Nuvalent: Optimistic Drug Efficacy and Financial Projections

TipRanksSep 9 20:35

Wedbush Maintains Nuvalent(NUVL.US) With Buy Rating, Maintains Target Price $99

Futu NewsSep 9 20:32

LifeSci Capital Maintains Nuvalent(NUVL.US) With Buy Rating, Raises Target Price to $105

Futu NewsSep 9 20:31

Wedbush Sticks to Its Buy Rating for Nuvalent (NUVL)

TipRanksSep 9 20:09

Barclays Maintains Nuvalent(NUVL.US) With Buy Rating, Maintains Target Price $100

Futu NewsSep 9 16:33

Barclays Maintains Nuvalent(NUVL.US) With Buy Rating, Maintains Target Price $100

Futu NewsSep 7 10:32